new icn messageflickr-free-ic3d pan white
Study Participant Receives NIAID/GSK Candidate Ebola Vaccine | by NIAID
Back to photostream

Study Participant Receives NIAID/GSK Candidate Ebola Vaccine

September 4, 2014 — A 26-year-old man, the third participant enrolled in VRC 207, receives a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical Center in Bethesda, Md. Credit: NIAID

27,632 views
8 faves
0 comments
Taken on September 4, 2014